DEINOVE (Alternext Paris: ALDEI), a technological company that designs, develops and markets a new generation of industrial processes based on Deinococci bacteria, is setting up a Standby Equity Facility (PACEO®) with Société Générale in accordance with the authorisation granted by the general meeting held on 3rd May 2012.
Emmanuel Petiot, CEO of DEINOVE, stated: “This standby equity facility allows reinforcing our flexibility and diversifying our sources of financing, while preserving our financial structure. The funds raised will contribute to finance our various ambitious projects in the green chemistry field (second-generation biofuels and chemical intermediates).”
Société Générale undertook to subscribe successive capital increases over the next 36-months, up to 450,000 shares in aggregate (i.e. 9.0% of the current share capital).